Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection.
Axelrad JE, Li T, Bachour SP, Nakamura TI, Shah R, Sachs MC, Chang S, Hudesman DP, Holubar SD, Lightner AL, Barnes EL, Cohen BL, Rieder F, Esen E, Remzi F, Regueiro M, Click B. Axelrad JE, et al. Inflamm Bowel Dis. 2023 Jun 1;29(6):888-897. doi: 10.1093/ibd/izac158. Inflamm Bowel Dis. 2023. PMID: 35905032 Free PMC article.
Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia.
Bernard-Raichon L, Venzon M, Klein J, Axelrad JE, Zhang C, Sullivan AP, Hussey GA, Casanovas-Massana A, Noval MG, Valero-Jimenez AM, Gago J, Putzel G, Pironti A, Wilder E; Yale IMPACT Research Team; Thorpe LE, Littman DR, Dittmann M, Stapleford KA, Shopsin B, Torres VJ, Ko AI, Iwasaki A, Cadwell K, Schluter J. Bernard-Raichon L, et al. Among authors: axelrad je. Nat Commun. 2022 Nov 1;13(1):5926. doi: 10.1038/s41467-022-33395-6. Nat Commun. 2022. PMID: 36319618 Free PMC article.
Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation.
Venzon M, Bernard-Raichon L, Klein J, Axelrad JE, Hussey GA, Sullivan AP, Casanovas-Massana A, Noval MG, Valero-Jimenez AM, Gago J, Wilder E; Yale IMPACT Research Team; Thorpe LE, Littman DR, Dittmann M, Stapleford KA, Shopsin B, Torres VJ, Ko AI, Iwasaki A, Cadwell K, Schluter J. Venzon M, et al. Among authors: axelrad je. Res Sq [Preprint]. 2021 Jul 27:rs.3.rs-726620. doi: 10.21203/rs.3.rs-726620/v1. Res Sq. 2021. PMID: 34341786 Free PMC article. Updated. Preprint.
Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
Lukin DJ, Lawlor G, Hudesman DP, Durbin L, Axelrad JE, Passi M, Cavaliere K, Coburn E, Loftus M, Jen H, Feathers A, Rosen MH, Malter LB, Swaminath A; IBD-ReMEdY Study (Research, Mentoring, Education New York). Lukin DJ, et al. Among authors: axelrad je. Inflamm Bowel Dis. 2019 Mar 14;25(4):775-781. doi: 10.1093/ibd/izy308. Inflamm Bowel Dis. 2019. PMID: 30312400
Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases.
Axelrad JE, Bazarbashi A, Zhou J, Castañeda D, Gujral A, Sperling D, Glass J, Agrawal M, Hong S, Lawlor G, Hudesman D, Chang S, Shah S, Yajnik V, Ananthakrishnan A, Khalili H, Colombel JF, Itzkowitz S; New York Crohn’s and Colitis Organization. Axelrad JE, et al. Clin Gastroenterol Hepatol. 2020 Apr;18(4):872-880.e1. doi: 10.1016/j.cgh.2019.06.042. Epub 2019 Jul 11. Clin Gastroenterol Hepatol. 2020. PMID: 31302306 Free PMC article.
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.
Haberman R, Axelrad J, Chen A, Castillo R, Yan D, Izmirly P, Neimann A, Adhikari S, Hudesman D, Scher JU. Haberman R, et al. N Engl J Med. 2020 Jul 2;383(1):85-88. doi: 10.1056/NEJMc2009567. Epub 2020 Apr 29. N Engl J Med. 2020. PMID: 32348641 Free PMC article. No abstract available.
110 results